Kretzschmar, Mirjam and Wiessing, Lucas and Jager, Johannes and Limburg, Wien and Postma, Maarten, eds. (2004) Hepatitis C and injecting drug use: impact, costs and policy options. EMCDDA Scientific Monograph Series; No. 7 Luxembourg: Office for Official Publications of the European Communities.
Preview | Title | Contact |
---|---|---|
|
PDF (EMCDDA Monograph 7)
- Published Version
1MB |
Hepatitis C infections occurring in recent years in the European Union may cost countries billions of euros in future healthcare, according to research published in this monograph.
A conglomeration of state-of-the-art research on hepatitis C, drug use and public health methods, this publication presents analyses on the impact and costs of the disease among injecting drug users, as a basis for sound policy-making. Other issues addressed include: quality of life; treatment, surveillance and prevention; and the cost-effectiveness of measures such as needle-exchange programmes and substitution therapy.
Hepatitis C affects an estimated 170 million people worldwide and at least a million, but possibly several million, people in Western Europe who are at risk of developing liver cirrhosis or liver cancer. It is a highly infectious and potentially fatal blood-borne disease that attacks the liver and for which there is as yet no vaccine.
Table of contents
• Part I: Natural history, treatment, quality of life, epidemiology and prevention
• Part II: Models of hepatitis C in injecting drug users
• Part III: Healthcare costs of drug-related hepatitis C infection
• Part IV: Wider costs of drug use
• Part V: Cost-effectiveness of needle and syringe programmes and methadone maintenance
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
A Substance use and dependence > Effects or consequences
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
Repository Staff Only: item control page